CEREVEL (NASDAQ:CERE) STOCK ALERT: Cerevel’s $45 Per Share Deal is Being Investigated by BFA Law, Shareholders are Urged to Contact the Firm
25. Juni 2024 05:06 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law about their rights relating to the upcoming merger.
CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Encouraged to Contact the Firm
22. Juni 2024 06:04 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law about their rights relating to the upcoming merger.
CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law about Continuing Investigation into the Offer
20. Juni 2024 07:07 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price
18. Juni 2024 06:13 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price
15. Juni 2024 06:37 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Encourages Investors to Contact the Firm
13. Juni 2024 07:35 ET
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urges Shareholders to Contact the Firm About Your Rights
11. Juni 2024 06:28 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your Rights
08. Juni 2024 05:12 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law about the $45 Merger Offer from AbbVie
05. Juni 2024 15:31 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
01. Juni 2024 05:36 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...